This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Shilpa Medicare Limited. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Vivek Vijaya Kumar Joshi: Innovator in Controlled Release Injectable Formulations
Introduction
Vivek Vijaya Kumar Joshi is a notable inventor based in Bengaluru, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of controlled release formulations. His innovative work has the potential to enhance patient care and medication efficacy.
Latest Patents
Vivek holds a patent for a formulation titled "Controlled release injectable ondansetron formulations." This invention relates to a controlled release injectable ondansetron formulation comprising ondansetron or a pharmaceutically acceptable salt, derivative, or metabolite thereof. The formulation is designed to release ondansetron over a period of at least two days from the date of administration, providing a more effective treatment option for patients.
Career Highlights
Vivek is currently associated with Shilpa Medicare Limited, a prominent company in the pharmaceutical sector. His role at the company allows him to leverage his expertise in drug formulation and development. With a focus on innovative solutions, he continues to contribute to advancements in the pharmaceutical industry.
Collaborations
Vivek collaborates with Purushothama Narasiyappa, working together to drive innovation and improve pharmaceutical formulations. Their partnership exemplifies the importance of teamwork in achieving groundbreaking results in the field.
Conclusion
Vivek Vijaya Kumar Joshi is a distinguished inventor whose work in controlled release injectable formulations is paving the way for improved therapeutic options. His contributions to the pharmaceutical industry are noteworthy and reflect his commitment to innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile